Occupational exposure to silica or asbestos is a common example of exposure to substances that can cause this form of pulmonary fibrosis. Diffuse parenchymal lung disease (DPLD) – This occurs in ...

Diffuse myocardial fibrosis (DMF) is a key process in cardiac disease. Clinical use has been limited as biopsy is needed to assess it. DMF blood collagen biomarkers are confounded and have limited ...

THE syndrome of hemochromatosis, consisting of diffuse parenchymal siderosis, parenchymal-cell damage and fibrosis, and dysfunction of the organs so involved, has been observed in several clinical ...

Please provide your email address to receive an email when new articles are posted on . Patients showed no difference in skin fibrosis whether they were given low-dose oral glucocorticoids or not.

Systemic sclerosis is a rare, chronic autoimmune rheumatic disorder characterized by diffuse fibrosis and vascular abnormalities in the skin, joints, and internal organs. TLY012, a PEGylated ...

Idiopathic pulmonary fibrosis is characterized by radiographically ... from a patient presenting with progressive dyspnea and diffuse parenchymal infiltrates. In Panel A, a low-power magnification ...

The UAB ILD Center offers clinical trial enrollment for patients with idiopathic pulmonary fibrosis and other forms of diffuse parenchymal lung disease as part of a multidisciplinary and integrated ...

Their work also showed that cardiac diffuse fibrosis—lesions that are associated with progression to heart failure, but are rarely assessed in patients with hypertrophic cardiomyopathy—can increase ...

While the human epididymis protein 4 (HE4) has been previously identified as a blood biomarker of fibrosis, the relationship HE4 has with other blood biomarkers has not been established. HE4 and ...

Diffuse myocardial fibrosis (DMF) is an important marker in many cardiac diseases, but its utility has been limited by the need for biopsy for its assessment. An accurate noninvasive method for ...